HB1375
Type: B Origin: House USA Comments: 0

Effective Act Ensuring The Fda Fully Examines Clinical Trial Impact And Vitalness Before Endorsement Act

Summary
User Reviews

AI Summary

The "EFFECTIVE Act" aims to enhance the scrutiny by the Food and Drug Administration (FDA) of clinical trials before approving medical products. It requires the FDA to thoroughly evaluate the impact and significance of clinical trials in determining a product's approval. This bill seeks to ensure that rigorous assessments are conducted prior to endorsing new medical treatments, potentially leading to increased safety and effectiveness of approved products.

Bill Activity

  • 2023-03-03: Introduced in House

  • 2023-03-03: Referred to the House Committee on Energy and Commerce.

  • 2023-03-10: Referred to the Subcommittee on Health.

Overall Bill Rating

0.0
0.0
0.0
0.0
0.0
0.0
Text Versions (1)
Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.